ReP USP - Resultado da busca

Artigo de periodico
Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant (2024)
Marques, Rodolfo Ferreira ; Gimenez, Alba Marina ; Caballero, Otávia; Simpson, Andrew; Salazar, Andres M; Amino, Rogerio ; Godin, Steven; Gazzinelli, Ricardo T, ; Soares, Irene da Silva
Source: Vaccine. Unidades: ICB, FCF
Subjects: MALÁRIA, VACINAS, PLASMODIUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARQUES, Rodolfo Ferreira et al. Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant. Vaccine, v. 42, n. 9, p. 2394-2406, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.vaccine.2024.02.070. Acesso em: 09 nov. 2024.
APA
Marques, R. F., Gimenez, A. M., Caballero, O., Simpson, A., Salazar, A. M., Amino, R., et al. (2024). Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant. Vaccine, 42( 9), 2394-2406. doi:10.1016/j.vaccine.2024.02.070
NLM
Marques RF, Gimenez AM, Caballero O, Simpson A, Salazar AM, Amino R, Godin S, Gazzinelli RT, Soares I da S. Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant [Internet]. Vaccine. 2024 ; 42( 9): 2394-2406.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1016/j.vaccine.2024.02.070
Vancouver
Marques RF, Gimenez AM, Caballero O, Simpson A, Salazar AM, Amino R, Godin S, Gazzinelli RT, Soares I da S. Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant [Internet]. Vaccine. 2024 ; 42( 9): 2394-2406.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1016/j.vaccine.2024.02.070
Artigo de periodico
Poly I: C elicits broader and stronger humoral and cellular responses to a Plasmodium vivax circumsporozoite protein malaria vaccine than Alhydrogel in mice (2024)
Gouvêa, Tiffany Bianca Lage da Costa ; Françoso, Katia Sanches; Marques, Rodolfo F; Gimenez, Alba Marina; Faria, Ana C. M; Cariste, Leonardo M; Dominguez, Mariana R; Vasconcelos, José Ronnie Carvalho ; Nakaya, Helder Takashi Imoto ; Silveira, Eduardo Lani Volpe da ; Soares, Irene da Silva
Source: Frontiers in Immunology. Unidade: FCF
Subjects: MALÁRIA, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOUVÊA, Tiffany Bianca Lage da Costa et al. Poly I: C elicits broader and stronger humoral and cellular responses to a Plasmodium vivax circumsporozoite protein malaria vaccine than Alhydrogel in mice. Frontiers in Immunology, v. 15, p. 1-16 art. 1331474, 2024Tradução . . Disponível em: https://dx.doi.org/10.3389/fimmu.2024.1331474. Acesso em: 09 nov. 2024.
APA
Gouvêa, T. B. L. da C., Françoso, K. S., Marques, R. F., Gimenez, A. M., Faria, A. C. M., Cariste, L. M., et al. (2024). Poly I: C elicits broader and stronger humoral and cellular responses to a Plasmodium vivax circumsporozoite protein malaria vaccine than Alhydrogel in mice. Frontiers in Immunology, 15, 1-16 art. 1331474. doi:10.3389/fimmu.2024.1331474
NLM
Gouvêa TBL da C, Françoso KS, Marques RF, Gimenez AM, Faria ACM, Cariste LM, Dominguez MR, Vasconcelos JRC, Nakaya HTI, Silveira ELV da, Soares I da S. Poly I: C elicits broader and stronger humoral and cellular responses to a Plasmodium vivax circumsporozoite protein malaria vaccine than Alhydrogel in mice [Internet]. Frontiers in Immunology. 2024 ; 15 1-16 art. 1331474.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.3389/fimmu.2024.1331474
Vancouver
Gouvêa TBL da C, Françoso KS, Marques RF, Gimenez AM, Faria ACM, Cariste LM, Dominguez MR, Vasconcelos JRC, Nakaya HTI, Silveira ELV da, Soares I da S. Poly I: C elicits broader and stronger humoral and cellular responses to a Plasmodium vivax circumsporozoite protein malaria vaccine than Alhydrogel in mice [Internet]. Frontiers in Immunology. 2024 ; 15 1-16 art. 1331474.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.3389/fimmu.2024.1331474
Artigo de periodico
Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape (2023)
Oliveira, Jamille Ramos ; Ruiz, Cesar Manuel Remuzgo ; Machado, Rafael Rahal Guaragna ; Urbanski, Alysson Henrique ; Magawa, Jhosiene Yukari; Daher, Isabela Pazotti; Urbanski, Alysson Henrique ; Schmitz, Gabriela Justamante Händel ; Arcuri, Helen Andrade; Ferreira, Marcelo Alves ; Sasahara, Greyce Luri ; Medeiros, Giuliana Xavier de ; Silva Júnior, Roberto Carlos Vieira da ; Rosa, Daniela Santoro ; Nakaya, Helder Takashi Imoto ; Gadermaier, Gabriele; Coelho, Verônica ; Santos, Keity Souza ; Durigon, Edison Luiz ; Boscardin, Silvia Beatriz ; Schechtman, Deborah ; Cunha Neto, Edecio; Kalil Filho, Jorge Elias ; Coelho, Veronica Porto Carreiro de Vasconcellos
Source: Frontiers in Immunology. Unidades: ICB, IQ, FM, FCF
Subjects: MICROBIOLOGIA, PARASITOLOGIA, ANTICORPOS, COVID-19, VACINAS VIRAIS, EPITOPOS, IMUNOGLOBULINAS, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA, PEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Jamille Ramos et al. Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape. Frontiers in Immunology, v. 13, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.1010105. Acesso em: 09 nov. 2024.
APA
Oliveira, J. R., Ruiz, C. M. R., Machado, R. R. G., Urbanski, A. H., Magawa, J. Y., Daher, I. P., et al. (2023). Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape. Frontiers in Immunology, 13, 1-15. doi:10.3389/fimmu.2022.1010105
NLM
Oliveira JR, Ruiz CMR, Machado RRG, Urbanski AH, Magawa JY, Daher IP, Urbanski AH, Schmitz GJH, Arcuri HA, Ferreira MA, Sasahara GL, Medeiros GX de, Silva Júnior RCV da, Rosa DS, Nakaya HTI, Gadermaier G, Coelho V, Santos KS, Durigon EL, Boscardin SB, Schechtman D, Cunha Neto E, Kalil Filho JE, Coelho VPC de V. Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape [Internet]. Frontiers in Immunology. 2023 ; 13 1-15.[citado 2024 nov. 09 ] Available from: https://doi.org/10.3389/fimmu.2022.1010105
Vancouver
Oliveira JR, Ruiz CMR, Machado RRG, Urbanski AH, Magawa JY, Daher IP, Urbanski AH, Schmitz GJH, Arcuri HA, Ferreira MA, Sasahara GL, Medeiros GX de, Silva Júnior RCV da, Rosa DS, Nakaya HTI, Gadermaier G, Coelho V, Santos KS, Durigon EL, Boscardin SB, Schechtman D, Cunha Neto E, Kalil Filho JE, Coelho VPC de V. Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape [Internet]. Frontiers in Immunology. 2023 ; 13 1-15.[citado 2024 nov. 09 ] Available from: https://doi.org/10.3389/fimmu.2022.1010105
Artigo de periodico
PVC containing silver nanoparticles with antimicrobial properties effective against SARS-CoV-2 (2023)
Silva, Daniel José da ; Gramcianinov, Guilherme B; Jorge, Pamela Z; Malaquias, Vanessa Barbosa ; Mori, Augusto Akira ; Hirata, Mario Hiroyuki ; Lopes, Sérgio A. M; Bueno, Luciano A; Champeau, Mathilde ; Carastan, Danilo Justino
Source: Frontiers in Chemistry. Unidade: FCF
Subjects: NANOCOMPOSITOS, PRATA, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniel José da et al. PVC containing silver nanoparticles with antimicrobial properties effective against SARS-CoV-2. Frontiers in Chemistry, v. 11, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.3389/fchem.2023.1083399. Acesso em: 09 nov. 2024.
APA
Silva, D. J. da, Gramcianinov, G. B., Jorge, P. Z., Malaquias, V. B., Mori, A. A., Hirata, M. H., et al. (2023). PVC containing silver nanoparticles with antimicrobial properties effective against SARS-CoV-2. Frontiers in Chemistry, 11, 1-15. doi:10.3389/fchem.2023.1083399
NLM
Silva DJ da, Gramcianinov GB, Jorge PZ, Malaquias VB, Mori AA, Hirata MH, Lopes SAM, Bueno LA, Champeau M, Carastan DJ. PVC containing silver nanoparticles with antimicrobial properties effective against SARS-CoV-2 [Internet]. Frontiers in Chemistry. 2023 ; 11 1-15.[citado 2024 nov. 09 ] Available from: https://doi.org/10.3389/fchem.2023.1083399
Vancouver
Silva DJ da, Gramcianinov GB, Jorge PZ, Malaquias VB, Mori AA, Hirata MH, Lopes SAM, Bueno LA, Champeau M, Carastan DJ. PVC containing silver nanoparticles with antimicrobial properties effective against SARS-CoV-2 [Internet]. Frontiers in Chemistry. 2023 ; 11 1-15.[citado 2024 nov. 09 ] Available from: https://doi.org/10.3389/fchem.2023.1083399
Artigo de periodico
Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or α synuclein in Caenorhabditis elegans (2023)
Guedes, Erika da Cruz; Erustes, Adolfo Garcia; Leão, Anderson H. F. F; Carneiro, César Alves; Abílio, Vanessa C; Zuardi, Antônio Waldo ; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Bincoletto, Cláudia; Smaili, Soraya S; Reckziegel, Patricia ; Pereira, Gustavo J. S
Source: Neurochemical Research. Unidades: FCF, FMRP
Subjects: CANABINOIDES, CAENORHABDITIS, DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUEDES, Erika da Cruz et al. Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or α synuclein in Caenorhabditis elegans. Neurochemical Research, v. 48, n. 8, p. 2390–2405, 2023Tradução . . Disponível em: https://dx.doi.org/10.1007/s11064-023-03905-z. Acesso em: 09 nov. 2024.
APA
Guedes, E. da C., Erustes, A. G., Leão, A. H. F. F., Carneiro, C. A., Abílio, V. C., Zuardi, A. W., et al. (2023). Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or α synuclein in Caenorhabditis elegans. Neurochemical Research, 48( 8), 2390–2405. doi:10.1007/s11064-023-03905-z
NLM
Guedes E da C, Erustes AG, Leão AHFF, Carneiro CA, Abílio VC, Zuardi AW, Hallak JEC, Crippa JA de S, Bincoletto C, Smaili SS, Reckziegel P, Pereira GJS. Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or α synuclein in Caenorhabditis elegans [Internet]. Neurochemical Research. 2023 ; 48( 8): 2390–2405.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1007/s11064-023-03905-z
Vancouver
Guedes E da C, Erustes AG, Leão AHFF, Carneiro CA, Abílio VC, Zuardi AW, Hallak JEC, Crippa JA de S, Bincoletto C, Smaili SS, Reckziegel P, Pereira GJS. Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or α synuclein in Caenorhabditis elegans [Internet]. Neurochemical Research. 2023 ; 48( 8): 2390–2405.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1007/s11064-023-03905-z
Artigo de periodico
Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape (2021)
Santos, Keity Souza ; Oliveira, Jamille Ramos de ; Machado, Rafael Rahal Guaragna ; Arcuri, Helen Andrade; Magawa, Jhosiene Yukari; Daher, Isabela Pazotti; Urbanski, Alysson Henrique; Schmitz, Gabriela Justamante Handel; Silva Júnior, Roberto Carlos Vieira; Durigon, Edison Luiz ; Boscardin, Silvia Beatriz ; Rosa, Daniela Santoro ; Schechtman, Deborah ; Cunha Neto, Edecio ; Gadermaier, Gabriele; Coelho, Verônica Porto Carreiro de Vasconcellos; Kalil, Jorge; Nakaya, Helder Takashi Imoto
Source: medRxiv (The Preprint Server For Health Sciences). Unidades: FM, ICB, IQ, FCF
Subjects: EPITOPOS, COVID-19, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Keity Souza et al. Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape. medRxiv (The Preprint Server For Health Sciences), p. 18 , 2021Tradução . . Disponível em: https://doi.org/10.1101/2021.03.11.21253399. Acesso em: 09 nov. 2024.
APA
Santos, K. S., Oliveira, J. R. de, Machado, R. R. G., Arcuri, H. A., Magawa, J. Y., Daher, I. P., et al. (2021). Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape. medRxiv (The Preprint Server For Health Sciences), 18 . doi:10.1101/2021.03.11.21253399
NLM
Santos KS, Oliveira JR de, Machado RRG, Arcuri HA, Magawa JY, Daher IP, Urbanski AH, Schmitz GJH, Silva Júnior RCV, Durigon EL, Boscardin SB, Rosa DS, Schechtman D, Cunha Neto E, Gadermaier G, Coelho VPC de V, Kalil J, Nakaya HTI. Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape [Internet]. medRxiv (The Preprint Server For Health Sciences). 2021 ; 18 .[citado 2024 nov. 09 ] Available from: https://doi.org/10.1101/2021.03.11.21253399
Vancouver
Santos KS, Oliveira JR de, Machado RRG, Arcuri HA, Magawa JY, Daher IP, Urbanski AH, Schmitz GJH, Silva Júnior RCV, Durigon EL, Boscardin SB, Rosa DS, Schechtman D, Cunha Neto E, Gadermaier G, Coelho VPC de V, Kalil J, Nakaya HTI. Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape [Internet]. medRxiv (The Preprint Server For Health Sciences). 2021 ; 18 .[citado 2024 nov. 09 ] Available from: https://doi.org/10.1101/2021.03.11.21253399

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Funding Agencies

Non normalized affiliation